Cargando…
Seroprevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Patients with Neuromuscular Disorders
High pre-existing antibodies against viral vectors reduce their functionality and may lead to adverse complications. To circumvent this problem in future gene therapy approaches, we tested the seroprevalence of a large range of human adenovirus types in patients with neuromuscular disorders (NMDs) t...
Autores principales: | Klann, Patrick Julian, Wang, Xiaoyan, Elfert, Anna, Zhang, Wenli, Köhler, Cornelia, Güttsches, Anne-Katrin, Jacobsen, Frank, Weyen, Ute, Roos, Andreas, Ehrke-Schulz, Eric, Ehrhardt, Anja, Vorgerd, Matthias, Bayer, Wibke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866721/ https://www.ncbi.nlm.nih.gov/pubmed/36680119 http://dx.doi.org/10.3390/v15010079 |
Ejemplares similares
-
Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic
por: Wang, Xiaoyan, et al.
Publicado: (2022) -
Comparative analysis of the impact of 40 adenovirus types on dendritic cell activation and CD8(+) T cell proliferation capacity for the identification of favorable immunization vector candidates
por: Wang, Xiaoyan, et al.
Publicado: (2023) -
Muscle Specific Promotors for Gene Therapy – A Comparative Study in Proliferating and Differentiated Cells
por: Dietz, Julienne, et al.
Publicado: (2023) -
Spectrum-Wide Exploration of Human Adenoviruses for Breast Cancer Therapy
por: Mach, Nicolas, et al.
Publicado: (2020) -
Novel Group C Oncolytic Adenoviruses Carrying a miRNA Inhibitor Demonstrate Enhanced Oncolytic Activity In Vitro and In Vivo
por: Doerner, Johannes, et al.
Publicado: (2022)